Systemic lupus erythematosus is associated with an increased risk for pulmonary manifestations, including ILD and pulmonary hypertension.

However, symptoms often overlap with those of systemic lupus erythematosus (SLE). These include: muscle and joint pain sometimes with swelling flu-like symptoms of fatigue and fever serositis ...

Biomarkers that reliably identify or even predict disease manifestations in systemic lupus erythematosus (SLE) are needed. In a recent issue of the Clinical Journal of the American Society of ...

The Lupus Foundation of America (LFA) is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in ...

Linkage studies type microsatellite markers across the whole genome in pedigrees with at least two systemic lupus erythematosus (SLE) patients and define a large linkage region. Association ...

Systemic lupus erythematosus (SLE) is the most common type of lupus. According to 2019 criteria from the ACR and EULAR, you must have antinuclear antibodies to receive an SLE diagnosis.

The Lupus Foundation of America describes lupus as a chronic disease that attacks the immune system, the part of the body that fights off disease and infections. Some of the most common symptoms ...

The following is a summary of “Factors associated with worsening interstitial fibrosis/tubular atrophy in lupus nephritis ...

Fate Therapeutics (NASDAQ:FATE) announced that the U.S. FDA granted Regenerative Medicine Advanced Therapy designation to ...

Background. A 20-year-old female patient with chronic hepatitis C virus infection and end-stage renal disease due to systemic lupus erythematosus was admitted to hospital with fever, pain in the ...